OAC Welcomes New Obesity Medication Accessibility
Slice of Healthcare Team
11/11/2025
Key highlights
- Medicare beneficiaries will pay just $50 per month for select obesity drugs.
- OAC praises move toward equitable access and affordable care for millions.
- Step forward in recognizing obesity as a chronic disease requiring evidence-based treatment.
- Initiative may open pathways for Medicare and Medicaid coverage of obesity medications.
- OAC continues advocacy for broad payer coverage and policy collaboration.
Source: PR Newswire
Notable Quote
“ The OAC has long urged leaders across government and healthcare to make obesity care accessible and affordable. ”
Joe Nadglowski, President and CEO at OAC
Why this matters
This announcement is pivotal as it addresses the accessibility of obesity treatments, which have been historically overlooked. By lowering costs and expanding coverage options, it offers hope to millions suffering from obesity, ultimately aiming to improve health outcomes and reduce the financial burden associated with this chronic disease. This development is particularly significant for the healthcare sector.
Expert Insights
Share Your Expert Insights
Have relevant experience or professional perspective? Add your thoughtful insights to this article.
